- Home
- BEDU vs KRON Comparison
BEDU vs KRON Comparison
Compare BEDU & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- KRON
- Stock Information
- Founded
- BEDU 1994
- KRON 2017
- Country
- BEDU United Kingdom
- KRON United States
- Employees
- BEDU N/A
- KRON 8
- Industry
- BEDU Other Consumer Services
- KRON Medicinal Chemicals and Botanical Products
- Sector
- BEDU Real Estate
- KRON Health Care
- Exchange
- BEDU Nasdaq
- KRON Nasdaq
- Market Cap
- BEDU 47.7M
- KRON 54.1M
- IPO Year
- BEDU 2017
- KRON 2020
- Fundamental
- Price
- BEDU N/A
- KRON N/A
- Analyst Decision
- BEDU
- KRON Buy
- Analyst Count
- BEDU 0
- KRON 3
- Target Price
- BEDU N/A
- KRON $1.63
- AVG Volume (30 Days)
- BEDU 3.4K
- KRON 1.4M
- Earning Date
- BEDU 08-01-2025
- KRON 08-07-2025
- Dividend Yield
- BEDU N/A
- KRON N/A
- EPS Growth
- BEDU N/A
- KRON N/A
- EPS
- BEDU N/A
- KRON N/A
- Revenue
- BEDU $224,321,752.00
- KRON $9,192,000.00
- Revenue This Year
- BEDU N/A
- KRON N/A
- Revenue Next Year
- BEDU N/A
- KRON N/A
- P/E Ratio
- BEDU N/A
- KRON N/A
- Revenue Growth
- BEDU N/A
- KRON 21.16
- 52 Week Low
- BEDU $1.35
- KRON $0.65
- 52 Week High
- BEDU $2.41
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- BEDU 54.28
- KRON 65.76
- Support Level
- BEDU $1.70
- KRON $0.87
- Resistance Level
- BEDU $1.80
- KRON $0.90
- Average True Range (ATR)
- BEDU 0.04
- KRON 0.01
- MACD
- BEDU -0.00
- KRON -0.00
- Stochastic Oscillator
- BEDU 53.57
- KRON 40.19
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.